Publications by authors named "E D Namiot"
Article Synopsis
- * A comprehensive analysis of 363 clinical trials from 2014 to 2024 revealed that most studies looked at ketamine for anesthesia and pain management, while esketamine primarily focused on TRD, with many trials reaching advanced phases (III and IV).
- * There is growing interest in using sub-anesthetic doses of ketamine to treat neuropsychiatric disorders such as major depression and schizophrenia, and research suggests that the number of studies and potential new treatments may continue
Major depressive disorder (MDD), commonly known as depression, affects over 300 million people worldwide as of 2018 and presents a wide range of clinical symptoms. The international clinical trials registry platform (ICTRP) introduced by WHO includes aggregated data from ClinicalTrials.gov and 17 other national registers, making it the largest clinical trial platform.
View Article and Find Full Text PDFObjectives: Diagnosing brain tumors is critical due to their complex nature. This review explores the potential of hybridization for diagnosing brain neoplasms, examining their attributes and applications in neurology and oncology.
Methods: The review surveys literature and cross-references findings with the OMIM database, examining 513 records.
Clinical trials are the gold standard for testing new therapies. Databases like ClinicalTrials.gov provide access to trial information, mainly covering the US and Europe.
View Article and Find Full Text PDFNanoparticles are heterologous small composites that are usually between 1 and 100 nanometers in size. They are applied in many areas of medicine with one of them being drug delivery. Nanoparticles have a number of advantages as drug carriers which include reduced toxic effects, increased bioavailability, and their ability to be modified for specific tissues or cells.
View Article and Find Full Text PDF